After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...
ANNA Richardson has just shared that despite vowing to never use fat jabs, she’s lost an incredible stone and a half thanks ...
Eli Lilly (LLY) stock is trading at record highs after the pharmaceutical company reached a deal with the White House to ...
Bizcommunity on MSN
Explainer: GLP-1s and weight management
South Africa is facing a significant weight problem. Statistics indicate that nearly one-third of men and about two-thirds of ...
While more exercise and fewer calories used to be the go-to medical advice for those needing help with obesity, there is growing recognition that this approach is not helpful for many people trying to ...
A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and Wegovy, is a step toward making them more affordable and accessible ...
Zacks Investment Research on MSN
Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock?
Eli Lilly and Company’s LLY stock has risen 18% in a month, driven mainly by a stellar third-quarter performance. Also, ...
This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...
Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...
Weight loss refers to a reduction in overall body weight, while fat loss specifically targets excess body fat, improving body ...
Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School ...
Topline nimacimab Phase 2a study data showed clinically meaningful weight loss in nimacimab/semaglutide combination cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results